Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Martinez L, Cords O, Horsburgh C, Andrews J, Acuna-Villaorduna C, Desai Ahuja S, Altet N, Augusto O, Baliashvili D, Basu S, Becerra M, Bonnet M, Henry Boom W, Borgdorff M, Boulahbal F, Carvalho A, Cayla J, Chakhaia T, Chan P, Cohen T, Croda J, Datta S, del Corral H, Denholm J, Dietze R, Dobler C, Donkor S, Egere U, Ellner J, Espinal M, Evans C, Fang C, Fielding K, Fox G, García L, García-Basteiro A, Geis S, Graham S, Grandjean L, Hannoun D, Hatherill M, Hauri A, Hesseling A, Hill P, Huang L, Huerga H, Hussain R, Jarlsberg L, Jones-López E, Kato S, Kato-Maeda M, Kampmann B, Kirchner H, Kritski A, Lange C, Lee C, Lee L, Lee M, Lemos A, Lienhardt C, Ling D, Liu Q, Lo N, Long R, Lopez-Varela E, Lu P, Magee M, Malone L, Mandalakas A, Martinson N, Mazahir R, Murray M, Netto E, Otero L, Parsonnet J, Reingold A, Schaaf H, Seddon J, Sharma S, Singh J, Singh S, Sloot R, Sotgiu G, Stein C, Iqbal N, Triasih R, Trieu L, van der Loeff M, Van der Stuyft P, van Schalkwyk C, Vashishtha R, Verhagen L, Villalba J, Wang J, Whalen C, Yoshiyama T, Zar H, Zellweger J, Zhu L. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. The Lancet. ; 395(10228):973-984.
Crawford F, Marx F, Zelner J, Cohen T. Transmission Modeling with Regression Adjustment for Analyzing Household-based Studies of Infectious Disease. Epidemiology. ; 31(2):238-247.
Marx F, Cohen T, Lombard C, Hesseling A, Dlamini S, Beyers N, Naidoo P. Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa. The International Journal of Tuberculosis and Lung Disease. ; 23(8):891-899.
Arifin S, Zimmer C, Trotter C, Colombini A, Sidikou F, LaForce F, Cohen T, Yaesoubi R. Cost-Effectiveness of Alternative Uses of Polyvalent Meningococcal Vaccines in Niger: An Agent-Based Transmission Modeling Study. Medical Decision Making. ; 39(5):553-567.
Yaesoubi R, Cohen T. Decision Analytics and Optimization in Disease Prevention and Treatment. ; :59-79.
Ngwatu B, Nsengiyumva N, Oxlade O, Mappin-Kasirer B, Nguyen N, Jaramillo E, Falzon D, Schwartzman K. The impact of digital health technologies on tuberculosis treatment: a systematic review. European Respiratory Journal. ; 51(1):1701596-.
Kunkel A, Lewnard J, Pitzer V, Cohen T. Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers. Antimicrobial Agents and Chemotherapy. ; 61(8):-.
Kendall E, Cohen T, Mitnick C, Dowdy D. Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective. International Journal of Infectious Diseases. ; 56:185-189.
Zimmer C, Yaesoubi R, Cohen T. A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models. PLOS Computational Biology. ; 13(1):e1005257-.
Manson A, Cohen K, Abeel T, Desjardins C, Armstrong D, Barry C, Brand J, Chapman S, Cho S, Gabrielian A, Gomez J, Jodals A, Joloba M, Jureen P, Lee J, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati A, Winglee K, Zalutskaya A, Via L, Cassell G, Dorman S, Ellner J, Farnia P, Galagan J, Rosenthal A, Crudu V, Homorodean D, Hsueh P, Narayanan S, Pym A, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai W, Cohen T, Hoffner S, Birren B, Earl A. Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance. Nature Genetics. ; 49(3):395-402.
Abel zur Wiesch P, Clarelli F, Cohen T. Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies. PLOS Computational Biology. ; 13(1):e1005321-.
Kendall E, Shrestha S, Cohen T, Nuermberger E, Dooley K, Gonzalez-Angulo L, Churchyard G, Nahid P, Rich M, Bansbach C, Forissier T, Lienhardt C, Dowdy D. Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLOS Medicine. ; 14(1):e1002202-.
Fofana M, Shrestha S, Knight G, Cohen T, White R, Cobelens F, Dowdy D. A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. ; 61(3):-.
Van Rie A, Cohen T. The contributions of Steve Lawn to the science, advocacy and policy of HIV-associated TB. The International Journal of Tuberculosis and Lung Disease. ; 20(12):1563-1564.
Houben R, Menzies N, Sumner T, Huynh G, Arinaminpathy N, Goldhaber-Fiebert J, Lin H, Wu C, Mandal S, Pandey S, Suen S, Bendavid E, Azman A, Dowdy D, Bacaër N, Rhines A, Feldman M, Handel A, Whalen C, Chang S, Wagner B, Eckhoff P, Trauer J, Denholm J, McBryde E, Cohen T, Salomon J, Pretorius C, Lalli M, Eaton J, Boccia D, Hosseini M, Gomez G, Sahu S, Daniels C, Ditiu L, Chin D, Wang L, Chadha V, Rade K, Dewan P, Hippner P, Charalambous S, Grant A, Churchyard G, Pillay Y, Mametja L, Kimerling M, Vassall A, White R. Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models. The Lancet Global Health. ; 4(11):e806-e815.
Kunkel A, Crawford F, Shepherd J, Cohen T. Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic. AIDS. ; 30(17):2715-2723.
Cohen T, Chindelevitch L, Misra R, Kempner M, Galea J, Moodley P, Wilson D. Reply to Chen et al. Journal of Infectious Diseases. ; 214(8):1287-1288.
Mitnick C, White R, Lu C, Rodriguez C, Bayona J, Becerra M, Burgos M, Centis R, Cohen T, Cox H, D'Ambrosio L, Danilovitz M, Falzon D, Gelmanova I, Gler M, Grinsdale J, Holtz T, Keshavjee S, Leimane V, Menzies D, Migliori G, Milstein M, Mishustin S, Pagano M, Quelapio M, Shean K, Shin S, Tolman A, van der Walt M, Van Deun A, Viiklepp P. Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method. European Respiratory Journal. ; 48(4):1160-1170.
Marx F, Floyd S, Ayles H, Godfrey-Faussett P, Beyers N, Cohen T. High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions. European Respiratory Journal. ; 48(4):1227-1230.
Mears J, Vynnycky E, Lord J, Borgdorff M, Cohen T, Crisp D, Innes J, Lilley M, Maguire H, McHugh T, Woltmann G, Abubakar I, Sonnenberg P. The prospective evaluation of the TB strain typing service in England: a mixed methods study. Thorax. ; 71(8):734-741.
Andre E, Isaacs C, Affolabi D, Alagna R, Brockmann D, de Jong B, Cambau E, Churchyard G, Cohen T, Delmee M, Delvenne J, Farhat M, Habib A, Holme P, Keshavjee S, Khan A, Lightfoot P, Moore D, Moreno Y, Mundade Y, Pai M, Patel S, Nyaruhirira A, Rocha L, Takle J, Trébucq A, Creswell J, Boehme C. Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. The International Journal of Tuberculosis and Lung Disease. ; 20(8):999-1003.
Zhang Z, Manjourides J, Cohen T, Hu Y, Jiang Q. Spatial measurement errors in the field of spatial epidemiology. International Journal of Health Geographics. ; 15(1):-.
Kunkel A, Abel zur Wiesch P, Nathavitharana R, Marx F, Jenkins H, Cohen T. Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis. BMC Infectious Diseases. ; 16(1):-.
Cohen T, Chindelevitch L, Misra R, Kempner M, Galea J, Moodley P, Wilson D. Within-Host Heterogeneity of. Journal of Infectious Diseases. ; 213(11):1796-1799.
Jezmir J, Cohen T, Zignol M, Nyakan E, Hedt-Gauthier B, Gardner A, Kamle L, Injera W, Carter E. Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya. PLOS ONE. ; 11(5):e0154142-.
Heidebrecht C, Podewils L, Pym A, Mthiyane T, Cohen T. Assessing Local Risk of Rifampicin-Resistant Tuberculosis in KwaZulu-Natal, South Africa Using Lot Quality Assurance Sampling. PLOS ONE. ; 11(4):e0153143-.
Yates T, Khan P, Knight G, Taylor J, McHugh T, Lipman M, White R, Cohen T, Cobelens F, Wood R, Moore D, Abubakar I. The transmission of Mycobacterium tuberculosis in high burden settings. The Lancet Infectious Diseases. ; 16(2):227-238.
Chindelevitch L, Colijn C, Moodley P, Wilson D, Cohen T. ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections. PLOS Computational Biology. ; 12(2):e1004475-.
Heidebrecht C, Podewils L, Pym A, Cohen T, Mthiyane T, Wilson D. Assessing the utility of Xpert® MTB/RIF as a screening tool for patients admitted to medical wards in South Africa. Scientific Reports. ; 6(1):-.
Zelner J, Murray M, Becerra M, Galea J, Lecca L, Calderon R, Yataco R, Contreras C, Zhang Z, Manjourides J, Grenfell B, Cohen T. Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data. Journal of Infectious Diseases. ; 213(2):287-294.
Colijn C, Cohen T. Whole-genome sequencing of Mycobacterium tuberculosis for rapid diagnostics and beyond. The Lancet Respiratory Medicine. ; 4(1):6-8.
Salvatore P, Becerra M, Abel zur Wiesch P, Hinkley T, Kaur D, Sloutsky A, Cohen T. Fitness Costs of Drug Resistance Mutations in Multidrug-Resistant. Journal of Infectious Diseases. ; 213(1):149-155.
Theron G, Jenkins H, Cobelens F, Abubakar I, Khan A, Cohen T, Dowdy D. Data for action: collection and use of local data to end tuberculosis. The Lancet. ; 386(10010):2324-2333.
Seddon J, Jenkins H, Liu L, Cohen T, Black R, Vos T, Becerra M, Graham S, Sismanidis C, Dodd P. Counting children with tuberculosis: why numbers matter. The International Journal of Tuberculosis and Lung Disease. ; 19(12):9-16.
Knight G, Colijn C, Shrestha S, Fofana M, Cobelens F, White R, Dowdy D, Cohen T. The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis. Clinical Infectious Diseases. ; 61(suppl 3):S147-S154.
Colijn C, Cohen T. How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance. eLife. ; 4:-.
Birger R, Kouyos R, Cohen T, Griffiths E, Huijben S, Mina M, Volkova V, Grenfell B, Metcalf C. The potential impact of coinfection on antimicrobial chemotherapy and drug resistance. Trends in Microbiology. ; 23(9):537-544.
Jia Z, Huang X, Wu H, Zhang T, Li N, Ding P, Sun Y, Liu Z, Wei F, Zhang H, Jiao Y, Ji Y, Zhang Y, Guo C, Li W, Mou D, Xia W, Li Z, Chen D, Yan H, Chen X, Zhao J, Meyers K, Cohen T, Mayer K, Salomon J, Lu Z, Dye C. HIV burden in men who have sex with men: a prospective cohort study 2007–2012. Scientific Reports. ; 5(1):-.
Kunkel A, Colijn C, Lipsitch M, Cohen T. How could preventive therapy affect the prevalence of drug resistance? Causes and consequences. Philosophical Transactions of the Royal Society B: Biological Sciences. ; 370(1670):20140306-.
Chindelevitch L, Menzies N, Pretorius C, Stover J, Salomon J, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal of The Royal Society Interface. ; 12(106):20150146-.
Chang H, Cohen T, Grad Y, Hanage W, O'Brien T, Lipsitch M. Origin and Proliferation of Multiple-Drug Resistance in Bacterial Pathogens. Microbiology and Molecular Biology Reviews. ; 79(1):101-116.
Mears J, Abubakar I, Cohen T, McHugh T, Sonnenberg P. Effect of study design and setting on tuberculosis clustering estimates using Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeats (MIRU-VNTR): a systematic review. BMJ Open. ; 5(1):e005636-e005636.
Menzies N, Cohen T, Murray M, Salomon J. Effect of empirical treatment on outcomes of clinical trials of diagnostic assays for tuberculosis. The Lancet Infectious Diseases. ; 15(1):16-17.
Odone A, Amadasi S, White R, Cohen T, Grant A, Houben R. The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis. PLoS ONE. ; 9(11):e112017-.
Kouyos R, Metcalf C, Birger R, Klein E, Abel zur Wiesch P, Ankomah P, Arinaminpathy N, Bogich T, Bonhoeffer S, Brower C, Chi-Johnston G, Cohen T, Day T, Greenhouse B, Huijben S, Metlay J, Mideo N, Pollitt L, Read A, Smith D, Standley C, Wale N, Grenfell B. The path of least resistance: aggressive or moderate treatment?. Proceedings of the Royal Society B: Biological Sciences. ; 281(1794):20140566-.
Huang C, Tchetgen E, Becerra M, Cohen T, Galea J, Calderon R, Yataco R, Contreras C, Zhang Z, Lecca L, Murray M. Cigarette smoking among tuberculosis patients increases risk of transmission to child contacts. The International Journal of Tuberculosis and Lung Disease. ; 18(11):1285-1291.
Zwerling A, White R, Vassall A, Cohen T, Dowdy D, Houben R. Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations. PLoS ONE. ; 9(10):e110558-.
Mears J, Abubakar I, Crisp D, Maguire H, Innes J, Lilley M, Lord J, Cohen T, Borgdorff M, Vynnycky E, McHugh T, Sonnenberg P. Prospective evaluation of a complex public health intervention: lessons from an initial and follow-up cross-sectional survey of the tuberculosis strain typing service in England. BMC Public Health. ; 14(1):-.
Jenkins H, Pagano M, Yuen C, Becerra M, Cohen T. The burden of tuberculosis disease in children–Authors' reply. The Lancet. ; 384(9951):1343-1344.
Langley I, Lin H, Egwaga S, Doulla B, Ku C, Murray M, Cohen T, Squire S. Assessment of the patient, health system, and population effects of Xpert MTB/RIF and alternative diagnostics for tuberculosis in Tanzania: an integrated modelling approach. The Lancet Global Health. ; 2(10):e581-e591.
What would you like to do?